eCORE
- Advanced Therapies and Advanced Interventions, Nanomedicine, Transplant & Donation
- Brain & Mind and Behaviour
- Chronic, Prevalent Diseases & Aging
Team
Group Leader
Anna Rosell Novel
Principal Investigator (PI)
Anna Rosell Novel, Mar Hernández Guillamon, Pilar Delgado Martínez, Joan Montaner Villalonga
Researchers
Olga Maisterra Santos, Antonio Palasí Franco, Maria Teresa Buongiorno, Fernando Ruiz Esteve
PhD Students
Paula García Rodríguez, Daisy Guamán Pilco, Marta Klimczak, Berta Páez Montserrat, Nicolás García Rodríguez, Alejandro Ballvé Martín, Fu Chen
Lab Technicians
Miguel García Gabilondo, Anna Penalba Morenilla, Kerrie Adrián Campbell, Itsasne de la Torre Sánchez, Laia Fernández Resano
Nursing and Technical Staff
Jesús Pizarro Gonzálvez, Neus Salvadó Pérez, Marcel Lamana Vallverdú, Belén Gutiérrez Iglesias, Diana Liébana Gutiérrez
Selected Publications
Arrue M, Penalba A, Rodriguez-Bodero A, Elicegui A, de Homdedeu M, Cruz MJ, Simats A, Rodriguez S, Buxo X, Garcia-Rodriguez N, Pizarro J, Turner MC, Delgado P, Rosell A.
Diesel exhaust particles exposure exacerbates pro-thrombogenic plasma features ex-vivo after cerebral ischemia and accelerates tPA-induced clot-lysis in hypertensive subjects.
J Cereb Blood Flow Metab. 2024 May;44(5):772-786.
DOI: 10.1177/0271678X231214826
IF: 4.9
Li W, Shi J, Yu Z, Garcia-Gabilondo M, Held A, Huang L, Deng W, Ning M, Ji X, Rosell A, Wainger BJ, Lo EH.
SLC22A17 as a Cell Death-Linked Regulator of Tight Junctions in Cerebral Ischemia.
Stroke. 2024 Jun;55(6):1650-1659.
DOI: 10.1161/STROKEAHA.124.046736
IF: 7.9
Bonaterra-Pastra A, Sole M, Lope-Piedrafita S, Lucas-Parra M, Castellote L, Marazuela P, Pancorbo O, Rodriguez-Luna D, Hernandez-Guillamon.
The presence of circulating human apolipoprotein J reduces the occurrence of cerebral microbleeds in a transgenic mouse model with cerebral amyloid angiopathy.
Alzheimers Research & Therapy. 2024 Jul 29;16(1):169.
DOI: 10.1186/s13195-024-01541-5
IF: 8.0
Ballve A, Pizarro J, Maisterra O, Riba-Llena I, Pujadas F, Jimenez-Balado J, Palasi A, Cirach M, Turner MC, Sunyer J, Delgado P.
Ambient air pollution, covert cerebrovascular disease and cognition: results from the ISSYS study.
Eur J Neurol. 2024 Oct;31(10):e16404
DOI: 10.1111/ene.16404
IF: 4.5
Medina-Dols A, Canellas G, Capo T, Sole M, Mola-Caminal M, Cullell N, Jaume M, Nadal-Salas L, Llinas J, Gomez L, Tur S, Jimenez C, Diaz RM, Carrera C, Muino E, Gallego-Fabrega C, Soriano-Tarraga C, Ruiz-Guerra L, Pol-Fuster J, Asensio V, Muncunill J, Fleischer A, Iglesias A, Giralt-Steinhauer E, Lazcano U, Fernandez-Perez I, Jimenez-Balado J, Gabriel-Salazar M, Garcia-Gabilondo M, Lei T, Torres-Aguila NP, Carcel-Marquez J, Llado J, Olmos G, Rosell A, Montaner J, Planas AM, Rabionet R, Hernandez-Guillamon , Jimenez-Conde J, Fernandez-Cadenas I, Vives-Bauza.
Role of PATJ in stroke prognosis by modulating endothelial to mesenchymal transition through the Hippo/Notch/PI3K axis.
Cell Death Discov. 2024 Feb 17;10(1):85.
DOI: 10.1038/s41420-024-01857-z
IF: 6.1
Selected Projects
RICORS-ICTUS-Enfermedades Vasculares
Principal Investigator: Anna Rosell
Agency: Fondo de Investigación Sanitaria – ISCIII (Redes Temáticas RICORS-RD21/0006/0007)
Funding: 250,220 €
Period: 2022-2024
ELAPSE-ND: European-Latin American and Caribbean collaborative project on personalized medicine for neurological disorders.
Principal Investigator: Mar Hernandez
Agency: Fondo de Investigación Sanitaria – ISCIII-4th EU-LAC Joint Call (AC22/00051).
Funding: 174,850 €
Period: 2023-2025
Testing the endovascular route for improved neuroprotection and neurorepair in stroke recovery.
Principal Investigator: Anna Rosell
Agency: Fondo de Investigación Sanitaria – ISCIII (Proyectos de Investigación en Salud-PI22/01055)
Funding: 141,570 €
Period: 2023-2025
Role of MFGE8 as potential biomarker and therapeutic target in cerebral amyloid angiopathy. F
Principal Investigator: Mar Hernández
Agency: Fondo de Investigación Sanitaria – ISCIII (proyectos de Investigación en Salud-PI23/00082)
Funding: 208,750€
Period: 2024-2026
Endovascular Delivery of therapeutic nanocarriers for stroke recovery (End-Stroke).
Principal Investigator: Anna Rosell
Agency: Fundació La Marató (202333-30-31)
Funding: 173,750€
Period: 2024-2026
Selected Dissemination Activities
Escolab program
Place: VHIR
Date: 01/01/1970
Brief: Participation at the Barcelona City Council's Escolab program, with which the VHIR opens its doors to ESO, baccalaureate and training students. We hosted several visits at to our laboratory.
International Day of Women and Girls in Science
Place: VHIR
Date: 25/02/2025
Brief: International Day of Women and Girls in Science: Communication pills for schools.
Xerrades 30 anys VHIR 'Recerca bàsica més clínica en benefici del pacient: ictus'
Place: Hospital Vall d'Hebron
Date: 01/01/1970
Brief: Participation in activities celebrating the 30th anniversary of VHIR with the society: 'Basic and clinical research for the benefit of the patient: stroke”. Cycle of six talks between our researchers, patients, relatives and representatives of different representative groups of society.
MORE INFO
